GuanxinⅤRelieves Ventricular Remodeling by Inhibiting Inflammation:Implication from Virtual Screening,Systematic Pharmacology,Molecular Docking,and Experimental Validation

Objective:To reveal the anti-inflammatory mechanism of GuanxinⅤ,which is prescribed for ventricular remodeling in clinical practice.Methods:GuanxinⅤ-,ventricular remodeling-,and inflammationrelated targets were obtained through an integrated strategy of virtual screening and systematic pharmacology,and then the shared targets were visualised with a Venn diagram.GuanxinⅤnetwork and the protein-protein interaction network were drawn,and enrichment analysis was conducted.Finally,the main results obtained from the integrated strategy were validated by molecular docking and in vivo experiments.Results:A total of 251,11,425,and 15,246 GuanxinⅤ-,ventricular remodeling-,and inflammation-related targets were acquired,respectively.Then,211 shared targets were considered to contribute to the mechanism of ventricular remodeling treated by GuanxinⅤ.Guanxin network and the protein-protein interaction network were drawn,and enrichment analysis showed some cardiovascular-related biological processes and signaling pathways.Molecular docking revealed that the GuanxinⅤ-derived compounds could align with key targets.Final in vivo experiments proved that GuanxinⅤreverses ventricular remodeling by inhibiting inflammation.Conclusion:GuanxinⅤrelieves ventricular remodeling by regulating inflammation,which provides new ideas for the anti-ventricular remodeling mechanism of GuanxinⅤ.